A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses
James T. Gordy(Johns Hopkins University), Richard B. Markham(Johns Hopkins University)
Cited by 9
Related Papers
Diversification of Subtype E Human Immunodeficiency Virus Type 1<i>env</i>in Heterosexual Seroconverters from Northern Thailand
|The Journal of Infectious Diseases|1998|28